We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.58B
AUM Growth
+$568M
Cap. Flow
+$189M
Cap. Flow %
3.39%
Top 10 Hldgs %
17.58%
Holding
1,590
New
158
Increased
732
Reduced
501
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Financials 10.71%
3 Healthcare 10.59%
4 Consumer Discretionary 9.99%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKAM icon
401
Akamai
AKAM
$16.6B
$2.99M 0.05%
25,619
+1,112
+5% +$124K
NVS icon
402
Novartis
NVS
$297B
$2.95M 0.05%
32,298
-1,292
-4% -$115K
FIW icon
403
First Trust Water ETF
FIW
$1.85B
$2.93M 0.05%
35,084
+1,146
+3% +$94.1K
BRK.A icon
404
Berkshire Hathaway Class A
BRK.A
$1.1T
$2.93M 0.05%
7
+1
+17% +$420K
ADSK icon
405
Autodesk
ADSK
$49.2B
$2.91M 0.05%
9,965
+3,188
+47% +$909K
LKQ icon
406
LKQ Corp
LKQ
$5.69B
$2.86M 0.05%
58,028
-863
-1% -$41.2K
OKTA icon
407
Okta
OKTA
$24.4B
$2.85M 0.05%
11,625
+3,328
+40% +$803K
ETV
408
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.7B
$2.84M 0.05%
174,662
+13,853
+9% +$222K
SPHD icon
409
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.35B
$2.84M 0.05%
64,389
+584
+0.9% +$26.1K
CPRT icon
410
Copart
CPRT
$27B
$2.83M 0.05%
85,744
-140
-0.2% -$4.34K
MD icon
411
Pediatrix Medical
MD
$2.16B
$2.79M 0.05%
92,487
+26,908
+41% +$794K
TRV icon
412
Travelers Companies
TRV
$79B
$2.79M 0.05%
18,627
+215
+1% +$33.4K
HSY icon
413
Hershey
HSY
$35.6B
$2.79M 0.05%
16,000
-386
-2% -$65K
SMCI icon
414
Super Micro Computer
SMCI
$18B
$2.79M 0.05%
791,600
CRSP icon
415
CRISPR Therapeutics
CRSP
$4.73B
$2.78M 0.05%
17,179
+6,635
+63% +$807K
AXTA icon
416
Axalta
AXTA
$7.63B
$2.76M 0.05%
90,494
+6,146
+7% +$195K
SWN
417
DELISTED
Southwestern Energy Company
SWN
$2.72M 0.05%
479,894
+58,438
+14% +$287K
TFI icon
418
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.05B
$2.71M 0.05%
51,905
+25,215
+94% +$1.31M
VSS icon
419
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$2.69M 0.05%
19,716
+283
+1% +$38.3K
DD icon
420
DuPont de Nemours
DD
$18.6B
$2.67M 0.05%
27,535
-1,301
-5% -$131K
NTR icon
421
Nutrien
NTR
$33.4B
$2.67M 0.05%
44,136
+20,011
+83% +$1.18M
SHW icon
422
Sherwin-Williams
SHW
$82.6B
$2.67M 0.05%
9,792
+105
+1% +$28.8K
SRE icon
423
Sempra
SRE
$58.3B
$2.67M 0.05%
40,248
-1,780
-4% -$122K
MPV
424
Barings Participation Investors
MPV
$175M
$2.66M 0.05%
193,694
+1,048
+0.5% +$14K
FTNT icon
425
Fortinet
FTNT
$117B
$2.65M 0.05%
55,710
-2,530
-4% -$108K

Similar funds

Oppenheimer & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer & Co held 1,590 positions worth $5.58B, up 11% from $5.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $189M of net new capital in Q2 2021, opening 158 new positions and adding to 732 existing holdings. Its largest new stake was Equity Commonwealth: 133,173 shares worth $3.49M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg Convertible Securities ETF, an estimated $8.63M trimmed.

  • Oppenheimer & Co's largest Q2 2021 buy was Equity Commonwealth: 133,173 shares worth $3.49M.
  • Oppenheimer & Co added most to Amazon in Q2 2021, an estimated $10.8M increase.
  • Oppenheimer & Co's biggest Q2 2021 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $8.63M.
  • Oppenheimer & Co fully exited Armstrong World Industries in Q2 2021, selling an estimated $7.38M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.58B portfolio in Q2 2021.
  • Oppenheimer & Co opened 158 new positions and closed 88 in Q2 2021.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $5.58B.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.